Skip to main content

Peer Review reports

From: High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment

Original Submission
24 Mar 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
23 Oct 2015 Editorially accepted
2 Nov 2015 Article published 10.1186/s12885-015-1840-6

You can find further information about peer review here.

Back to article page